Pricing Log in Create free account
Friday 6 November 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024.

Revenue
+2.11%
EPS
+7.51%
Free cash flow
+38.9%
Total debt
+1,765.6%

Quarter to June 2026, against a year earlier

261.01 19.55 +8.10%
Market cap
$96.4B
P/E
0.0×
Fwd P/E
−26.1×
Dividend yield
—
F-score
3/9
Altman Z
2.46
Beneish M
−3.52
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Moderna, Inc. (MRNA) EV/EBITDA

Alert me on EV/EBITDA

Moderna, Inc. has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 125× (June 2021) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 6.3× (7.52%)
FY2021 6.8× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.7× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
30 more quarters

Against its own ten years

Low 0.0× High 125×
Ten-year median 0.0×
Current reading's percentile 67

EV/EBITDA against peers

Company EV/EBITDA
ROIV Roivant Sciences Ltd. compare n/m
MRNA Moderna, Inc. n/m
RVMD Revolution Medicines, Inc. compare n/m
REGN Regeneron Pharmaceuticals, Inc. compare 16.0×
RPRX Royalty Pharma PLC compare 24.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 28.6×
VRTX Vertex Pharmaceuticals Incorporated compare 29.7×
ARGX argenex SE compare 30.4×
GMAB Genmab A/S Sponsored ADR compare 31.0×
Biotechnology industry median 0.7×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MRNA